Wei (David) Ruan, the former owner of eRx Pharmacy in Calgary's Sunalta neighborhood,has been disciplined for professional misconduct. The Alberta College of Pharmacy found that Ruan falsified records and dispensed methadone without proper physician authorization.

Advertisement

Complaints from CUPS and the Calgary Drop-In Centre

The investigation into Wei (David) Ruan began on September 19, 2025, after a physician from the Calgary Urban Project Society (CUPS) flagged irregularities in opioid agonist therapy. According to the college's 31-page disciplinary decision, the physician noticed that medication dosages were being altered without the knowledge of the prescribing doctors.

Shortly after the initial probe started, the medical director of the Calgary Drop-In Centre raised additional alarms on September 30. The reports indicated that eRx Pharmacy had been providing patients with take-home methadone doses,a high-risk practice that occurred without the necessary authorization from the physicians managing the patients' care.

The 18-month prescription extensions and Netcare falsifications

During a heaaring on July 27, 2026, Wei (David) Ruan admitted to several grave breaches of professional standards. As reported in the disciplinary findings, Ruan extended methadone prescriptions for periods as long as 18 months without conducting the required patient assessments or consulting the original prescribers.

The misconduct extended to the digital record-keeping systems used to track patient health. Ruan admitted to creating false pharmacy and Netcare records to document medication dispensing that never actually took place. Additionally, the tribunal found that Ruan prescribed benzodiazepines without documenting whether such a combination with methadone was safe or appropriate for the patients involved.

The fragility of Opioid Agonist Therapy safeguards in Alberta

The case of eRx Pharmacy underscores the precarious nature of Opioid Agonist Therapy (OAT), where pharmacists serve as the final line of defense against overdose and diversion. In Alberta, witnessed ingestion is a critical safety mechanism designed to ensure that high-dose opioids are consumed as prescribed rather than stockpiled or sold.

By permitting staff to ignore missed doses and bypassing witnessed ingestion requirements , Wei (David) Ruan effectively dismantled the safety net for a vulnerable population. this incident echoes a broader systemic tension in community pharmacy, where the pressure for efficiency can sometimes clash with the rigorous, time-consuming documentation required for high-risk psychiatric and addiction medications.

The missing details on patient outcomes at eRx Pharmacy

While the tribunal focused on the breach of regulatory obligations, several critical questions remain unanswered. The source material does not specify whether any of the patients at eRx Pharmacy suffered adverse health effects or overdoses as a direct result of the unauthorized dosing and lack of assessments.

Furthermore, the report does not detail the specific disciplinary penalties imposed on Wei (David) Ruan beyond the finding of misconduct. It remains unclear if the Alberta College of Pharmacy has suspended Ruan's license or if eRx Pharmacy has ceased operations entirely following the August 25 decision.